Efficacy and safety of tirofiban in high-risk patients with non-ST-segment elevation acute coronary syndromes.

Yan, Zhenxian

Efficacy and safety of tirofiban in high-risk patients with non-ST-segment elevation acute coronary syndromes. [electronic resource] - Clinical cardiology Sep 2009 - E40-4 p. digital

Publication Type: Journal Article; Randomized Controlled Trial

1932-8737

10.1002/clc.20475 doi


Acute Coronary Syndrome--drug therapy
Aged
Angioplasty, Balloon, Coronary--adverse effects
Biomarkers--blood
Creatine Kinase, MB Form--blood
Double-Blind Method
Electrocardiography
Female
Heart Diseases--blood
Hemorrhage--chemically induced
Humans
Male
Middle Aged
Platelet Aggregation--drug effects
Platelet Aggregation Inhibitors--adverse effects
Prospective Studies
Risk Assessment
Thrombocytopenia--chemically induced
Time Factors
Tirofiban
Treatment Outcome
Troponin I--blood
Tyrosine--adverse effects